Clinical Cancer Research Bridging the Lab and the Clinic in Cancer Medicine Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bochner, B. H.
Right arrow Articles by Cote, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bochner, B. H.
Right arrow Articles by Cote, R. J.

Clinical Cancer Research, Vol 3, Issue 9 1615-1622, Copyright © 1997 by American Association for Cancer Research


ARTICLES

Relationship of tumor angiogenesis and nuclear p53 accumulation in invasive bladder cancer

BH Bochner, D Esrig, S Groshen, M Dickinson, N Weidner, PW Nichols, DG Skinner and RJ Cote
Departments of Pathology, Urology, and Preventative Medicine, University of Southern California, Los Angeles, California 90033, USA.

The purpose of this investigation was to evaluate the relationship between tumor angiogenesis and nuclear p53 accumulation in invasive bladder cancer. We studied 161 patients with invasive transitional cell carcinoma of the bladder who had previously undergone radical cystectomy. Analysis was performed to determine the presence of p53 nuclear accumulation and extent of tumor-associated angiogenesis. p53 status identified a group of patients at high risk for tumor progression (p53-altered tumors), and microvessel density determinations added additional prognostic information by identifying a subset of aggressive tumors within the wild-type p53 subgroup. At 5 years, patients with tumors exhibiting no evidence of p53 alterations and low microvessel counts demonstrated 3% recurrence and 88% survival, compared to 43% recurrence and 59% overall survival for patients with intermediate vessel counts and 61% recurrence and 43% overall survival for patients with the highest vessel counts (P < 0.001 and P = 0.003, respectively). Angiogenesis also provides additional prognostic information to patients with tumors that demonstrate p53 alterations. An association between angiogenesis and p53 status did exist (P = 0. 05); however, 27% of the tumors that showed no evidence of p53 alterations exhibited high microvessel counts, and 26% of tumors with evidence of p53 alterations had low microvessel counts. Tumor-associated angiogenesis adds additional useful prognostic information to that which is obtained from p53 status in patients with invasive transitional cell carcinoma of the bladder. Although an association between p53 status and the degree of angiogenesis was identified, other factors appear to play a role in the regulation of tumor-induced neovasularization.


This article has been cited by other articles:


Home page
JCOHome page
A. P. Mitra, R. H. Datar, and R. J. Cote
Molecular Pathways in Invasive Bladder Cancer: New Insights Into Mechanisms, Progression, and Target Identification
J. Clin. Oncol., December 10, 2006; 24(35): 5552 - 5564.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
L. Santos, C. Costa, S. Pereira, M. Koch, T. Amaro, F. Cardoso, T. Guimaraes, M. J. Bento, F. Lobo, S. Pinto, et al.
Neovascularisation is a prognostic factor of early recurrence in T1/G2 urothelial bladder tumours
Ann. Onc., September 1, 2003; 14(9): 1419 - 1424.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
J. I. Izawa and C. P.N. Dinney
The role of angiogenesis in prostate and other urologic cancers: a review
Can. Med. Assoc. J., March 1, 2001; 164(5): 662 - 670.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Muscheck, H. Abol-Enein, K. Chew, D. Moore II, V. Bhargava, M.A. Ghoneim, P.R. Carroll, and F.M. Waldman
Comparison of genetic changes in schistosome-related transitional and squamous bladder cancers using comparative genomic hybridization
Carcinogenesis, September 1, 2000; 21(9): 1721 - 1726.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Burchardt, T. Burchardt, A. Shabsigh, A. De La Taille, M. C. Benson, and I. Sawczuk
Current Concepts in Biomarker Technology for Bladder Cancers
Clin. Chem., May 1, 2000; 46(5): 595 - 605.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.